Medico Remedies Limited

NSE: MEDICO · Pharmaceuticals · sector

₹20.08NSE close 2026-10-26

Key numbers

Market cap₹167 cr

Price₹20.08

52w high / low₹57 / ₹20

P/E12.0xSector median 27.9x

P/B2.2xSector median 2.9x

Book value₹9.1

Dividend yield–Sector median 0.48%

ROE20.1%Sector median 11.7%

ROCE22.2%Sector median 12.3%

OPM7.4%Sector median 14.0%

Debt / equity0.25xSector median 0.16x

EV/EBITDA10.4xSector median 18.6x

Interest cover10.8x

Current ratio1.66x

Sales growth 3y+13.7%Sector median +9.6%

Profit growth 3y+21.9%Sector median +13.3%

PEG0.55x

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹4 cr vs borrowings ₹19 cr (FY26): borrowings are higher by ₹15 cr.
Operating profit covered interest 10.8x in the last 12 months.
Operating cash flow was below net profit in 3 of the last 4 years (FY26, FY25, FY24).
Revenue was higher than a year earlier in 4 of the last 4 quarters.
Other income was 47% of net profit in the last 12 months.
Debtor days went from 125 (FY24) to 145 (FY26).
No dividend in the last 4 financial years.
Price ₹20.08 on 2026-10-26: -64.7% from the 52-week high, 0.0% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹77.95 · low ₹20.08

Quarterly results

₹ cr	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	39	39	41	38	53	59	57	69
EBITDA	2	3	7	3	3	4	7	3
OPM %	6.1%	7.9%	16.2%	7.4%	5.2%	7.4%	12.6%	4.8%
Other income	1	1	0	1	2	1	3	1
Net profit	2	3	4	2	3	3	6	3
EPS (₹)	0.19	0.32	0.52	0.22	0.31	0.35	0.71	0.30
Revenue YoY					+33.8%	+48.6%	+37.6%	+81.4%
Profit YoY					+65.8%	+9.5%	+35.0%	+38.5%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY23	FY24	FY25	FY26	TTM
Revenue	140	145	151	206	238
EBITDA	10	13	15	17	18
Net profit	7	8	10	13	14
EPS (₹)	0.87	1.00	1.22	1.58	1.67
Revenue growth		+3.2%	+4.2%	+36.7%	+50.0%
Profit growth		+14.5%	+21.7%	+30.0%	+33.7%
Dividend / share (₹)	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+13.7%	–	+50.0%
Net profit	+21.9%	–	+33.7%
EPS	+22.0%	–	–
Share price	–	-36.3% (2y)	-59.1%

Balance sheet

₹ cr	FY23	FY24	FY25	FY26
Shareholders' equity	44	52	62	75
Borrowings	10	8	15	19
Cash & equivalents	2	2	3	4
Total assets	87	96	120	153
Fixed assets	20	20	21	20
Capital work in progress	2	1	1	3
Investments	0	0	0	0
Receivables	36	50	57	82
Inventory	20	16	27	30
Payables	31	32	35	49

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY23	FY24	FY25	FY26
Cash from operations	8	2	5	6
Cash from investing	-7	-3	-3	-5
Cash from financing	-2	-0	-1	-1
Capex	0	0	0	0
Free cash flow	8	2	5	6

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY23	FY24	FY25	FY26
ROE %	16.5%	15.8%	16.2%	17.4%
ROCE %	20.2%	20.1%	19.0%	21.1%
Debtor days	94	125	138	145
Inventory days	69	54	90	72
Payable days	108	105	117	119
Cash conversion cycle (days)	55	74	111	98
Working capital days	60	78	96	91

Shareholding

Holder	% (2026-09-30)
Promoters	61.38%
FIIs	0.60%
DIIs	0.00%
of which Mutual funds	0.00%
of which Insurance	0.00%
Government	0.00%
Public (non-institutions)	38.02%

Quarter	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters %	66.83%	63.79%	62.59%	61.38%	61.38%	61.38%	61.38%	61.38%

Promoter group	%
Haresh Kapurlal Mehta	20.22%
Mehta Rishit Hareshbhai	12.65%
Harshit Haresh Mehta	10.39%
Rita H Mehta	8.05%
Shweta Harshit Mehta	5.88%
Priyal Rishit Mehta	4.19%
Haresh K Mehta HUF	0.00%
Harshit H Mehta HUF	0.00%

17,716 shareholders. Pledged: – of promoter shares.

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
MEDICO	₹167 cr	12.0x	2.2x	20.1%	22.2%	7.4%	+13.7%	–

All 185 companies in Pharmaceuticals →

Dividends & corporate actions

Ex-date	Action	Detail
2024-08-29	Other	Annual General Meeting
2023-08-17	Other	Annual General Meeting
2023-03-16	Split	Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
2022-09-13	Other	Annual General Meeting

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	MEDICO
BSE code	540937
ISIN	INE630Y01024
Face value	₹2.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.